Vistin Pharma ASA (VISTN) — Cash Flow Quality Index
Vistin Pharma ASA (VISTN) has a Cash Flow Quality Index of -0.17x as of March 2026. Operating cash flow of Nkr-3.67 Million is below net income of Nkr21.49 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore VISTN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Vistin Pharma ASA Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Vistin Pharma ASA across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Vistin Pharma ASA (VISTN) cash conversion ratio.
Annual Cash Flow Quality Index for Vistin Pharma ASA (2016–2025)
Year-by-year earnings quality comparison for Vistin Pharma ASA.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.04x | Nkr78.04 Million | Nkr74.75 Million | ▼ -22.1% |
| 2024 | 1.34x | Nkr107.86 Million | Nkr80.45 Million | ▼ -13.4% |
| 2023 | 1.55x | Nkr90.59 Million | Nkr58.52 Million | ▲ +181.4% |
| 2021 | 0.55x | Nkr13.68 Million | Nkr24.87 Million | ▲ +92.4% |
| 2019 | 0.29x | Nkr18.93 Million | Nkr66.20 Million | ▲ +111.8% |
| 2017 | 0.14x | Nkr9.51 Million | Nkr70.40 Million | ▼ -96.8% |
| 2016 | 4.17x | Nkr53.84 Million | Nkr12.92 Million | — |